DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $367,754 | +1.6% | 1,482 | -1.8% | 0.03% | +8.3% |
| Q2 2023 | $362,106 | -25.5% | 1,509 | -21.8% | 0.02% | -11.1% |
| Q1 2023 | $486,338 | -11.3% | 1,930 | -6.5% | 0.03% | -25.0% |
| Q4 2022 | $548,147 | -0.3% | 2,065 | -3.0% | 0.04% | -10.0% |
| Q3 2022 | $550,000 | +2.0% | 2,129 | +0.1% | 0.04% | +5.3% |
| Q2 2022 | $539,000 | -41.4% | 2,127 | -32.2% | 0.04% | -32.1% |
| Q1 2022 | $920,000 | -7.6% | 3,138 | +3.7% | 0.06% | -9.7% |
| Q4 2021 | $996,000 | +77.9% | 3,027 | +64.6% | 0.06% | +44.2% |
| Q3 2021 | $560,000 | +27.0% | 1,839 | +11.9% | 0.04% | +26.5% |
| Q2 2021 | $441,000 | +20.8% | 1,643 | +1.4% | 0.03% | +9.7% |
| Q1 2021 | $365,000 | -10.1% | 1,621 | -11.2% | 0.03% | -18.4% |
| Q4 2020 | $406,000 | +3.3% | 1,826 | +0.1% | 0.04% | +26.7% |
| Q3 2020 | $393,000 | +37.4% | 1,825 | +12.9% | 0.03% | -23.1% |
| Q2 2020 | $286,000 | +21.2% | 1,617 | -5.3% | 0.04% | +2.6% |
| Q1 2020 | $236,000 | -10.9% | 1,708 | -1.0% | 0.04% | 0.0% |
| Q4 2019 | $265,000 | +6.4% | 1,726 | +0.1% | 0.04% | -7.3% |
| Q3 2019 | $249,000 | -9.1% | 1,724 | -10.0% | 0.04% | -36.9% |
| Q2 2019 | $274,000 | -82.4% | 1,915 | -83.8% | 0.06% | -81.2% |
| Q1 2019 | $1,557,000 | -38.3% | 11,796 | +47084.0% | 0.35% | -62.4% |
| Q2 2016 | $2,525,000 | – | 25 | – | 0.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |